Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
Randomized Phase III Trial of Lenalidomide Versus Observation Alone in Patients with Asymptomatic HighRisk Smoldering Multiple Myeloma.
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209